MARKET

INGN

INGN

Inogen
NASDAQ

Real-time Quotes | Nasdaq Last Sale

34.00
-0.72
-2.07%
Opening 12:17 08/06 EDT
OPEN
34.32
PREV CLOSE
34.72
HIGH
34.32
LOW
32.93
VOLUME
141.86K
TURNOVER
--
52 WEEK HIGH
76.89
52 WEEK LOW
28.57
MARKET CAP
749.62M
P/E (TTM)
54.11
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 6 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average INGN stock price target is 34.33 with a high estimate of 38.00 and a low estimate of 30.00.

EPS

INGN News

More
Inogen EPS beats by $0.20, misses on revenue
Inogen (NASDAQ:INGN): Q2 GAAP EPS of $0.12 beats by $0.20. Revenue of $71.69M (-29.1% Y/Y) misses by $8.27M. Press Release
seekingalpha · 1d ago
Inogen Inc (INGN) Q2 2020 Earnings Call Transcript
Joining me from Inogen is CEO, Scott Wilkinson and CFO and Co-Founder Ali Bauerlein. Earlier today, Inogen released financial results for the second quarter of 2020. As a reminder, the information presented today will include forward-looking statements, incl
Motley Fool · 1d ago
Inogen (INGN) Q2 Earnings Beat Estimates
Inogen (INGN) delivered earnings and revenue surprises of 250.00% and -10.08%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 1d ago
Inogen Q2 EPS $0.12 Beats $(0.06) Estimate, Sales $71.69M Miss $79.96M Estimate
Inogen (NASDAQ:INGN) reported quarterly earnings of $0.12 per share which beat the analyst consensus estimate of $(0.06) by 300 percent. This is a 73.33 percent decrease over earnings of $0.45 per share from the same
Benzinga · 1d ago
Inogen Announces Second Quarter 2020 Financial Results
Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results for the three-month period ended June 30, 2020.
Business Wire · 1d ago
Inogen: A Boom And Bust Story
Seeking Alpha · 07/29 16:26
Earnings Preview: Inogen (INGN) Q2 Earnings Expected to Decline
Inogen (INGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks · 07/28 16:33
Inogen: Backdoor Bet On Travel
Seeking Alpha · 07/27 15:27

Industry

Medical Equipment, Supplies & Distribution
-1.83%
Healthcare Equipment & Supplies
-1.78%

Hot Stocks

Symbol
Price
%Change

About INGN

Inogen, Inc. is a medical technology company. The Company develops, manufactures and markets portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The Company's Inogen One systems concentrate the air around the patient to offer a single source of supplemental oxygen anytime, anywhere with a portable device. Its three portable product offerings, the Inogen One G4, Inogen One G3 and Inogen One G2, at approximately 2.8, 4.8 and 7.0 pounds with a single battery, respectively. Its Inogen One G4, Inogen One G3 and Inogen One G2 are sub-3, sub-5 and sub-10 pound portable oxygen concentrators, respectively. All of its Inogen One systems are equipped with Intelligent Delivery Technology. The Inogen At Home stationary oxygen concentrator allows it to access the non-ambulatory oxygen patient market and serves as a backup to its Inogen One system for ambulatory patients on its rental service.
More

Webull offers kinds of Inogen Inc stock information, including NASDAQ:INGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, INGN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading INGN stock methods without spending real money on the virtual paper trading platform.